Correlation
The correlation between AMPH and ARCT is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
AMPH vs. ARCT
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Arcturus Therapeutics Holdings Inc. (ARCT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or ARCT.
Performance
AMPH vs. ARCT - Performance Comparison
Loading data...
Key characteristics
AMPH:
-0.99
ARCT:
-0.91
AMPH:
-1.38
ARCT:
-1.49
AMPH:
0.83
ARCT:
0.83
AMPH:
-0.60
ARCT:
-0.73
AMPH:
-1.26
ARCT:
-1.13
AMPH:
30.84%
ARCT:
59.39%
AMPH:
39.69%
ARCT:
74.14%
AMPH:
-64.63%
ARCT:
-92.79%
AMPH:
-60.45%
ARCT:
-89.87%
Fundamentals
AMPH:
$1.21B
ARCT:
$339.82M
AMPH:
$2.76
ARCT:
-$2.52
AMPH:
1.65
ARCT:
2.37
AMPH:
1.61
ARCT:
1.48
AMPH:
$728.26M
ARCT:
$135.17M
AMPH:
$365.89M
ARCT:
$136.31M
AMPH:
$240.52M
ARCT:
-$60.17M
Returns By Period
In the year-to-date period, AMPH achieves a -30.76% return, which is significantly lower than ARCT's -26.16% return.
AMPH
-30.76%
5.33%
-43.11%
-39.00%
-11.54%
6.64%
5.00%
ARCT
-26.16%
-2.19%
-31.68%
-67.44%
-14.26%
-20.29%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. ARCT — Risk-Adjusted Performance Rank
AMPH
ARCT
AMPH vs. ARCT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AMPH vs. ARCT - Dividend Comparison
Neither AMPH nor ARCT has paid dividends to shareholders.
Drawdowns
AMPH vs. ARCT - Drawdown Comparison
The maximum AMPH drawdown since its inception was -64.63%, smaller than the maximum ARCT drawdown of -92.79%. Use the drawdown chart below to compare losses from any high point for AMPH and ARCT.
Loading data...
Volatility
AMPH vs. ARCT - Volatility Comparison
The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 11.45%, while Arcturus Therapeutics Holdings Inc. (ARCT) has a volatility of 22.35%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AMPH vs. ARCT - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. ARCT - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.25M and revenue of 170.53M. Therefore, the gross margin over that period was 50.0%.
ARCT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported a gross profit of 29.38M and revenue of 29.38M. Therefore, the gross margin over that period was 100.0%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported an operating income of 37.29M and revenue of 170.53M, resulting in an operating margin of 21.9%.
ARCT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported an operating income of -16.83M and revenue of 29.38M, resulting in an operating margin of -57.3%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a net income of 25.29M and revenue of 170.53M, resulting in a net margin of 14.8%.
ARCT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported a net income of -14.08M and revenue of 29.38M, resulting in a net margin of -47.9%.